Enhabit (EHAB) Projected to Post Earnings on Wednesday

Enhabit (NYSE:EHAB) is projected to post its quarterly earnings results after the market closes on Wednesday, March 5th. Analysts expect Enhabit to post earnings of $0.07 per share and revenue of $259.11 million for the quarter. Individual that are interested in participating in the company’s earnings conference call can do so using this link.

Enhabit Stock Performance

NYSE EHAB opened at $8.26 on Wednesday. Enhabit has a 52-week low of $6.85 and a 52-week high of $11.74. The company has a fifty day moving average of $8.10 and a 200-day moving average of $7.90. The company has a market capitalization of $415.09 million, a P/E ratio of -3.56 and a beta of 1.83. The company has a debt-to-equity ratio of 0.85, a quick ratio of 1.46 and a current ratio of 1.46.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on the company. Jefferies Financial Group raised Enhabit from a “hold” rating to a “buy” rating and lifted their price target for the stock from $8.25 to $9.50 in a research note on Monday, December 9th. Leerink Partners restated a “market perform” rating and issued a $8.00 target price (down previously from $8.50) on shares of Enhabit in a research report on Tuesday, November 19th. One investment analyst has rated the stock with a sell rating, four have given a hold rating and one has assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average target price of $8.75.

Insider Activity

In other news, Director Stuart M. Mcguigan purchased 15,000 shares of the company’s stock in a transaction on Tuesday, December 10th. The stock was acquired at an average price of $8.81 per share, with a total value of $132,150.00. Following the transaction, the director now directly owns 46,810 shares of the company’s stock, valued at approximately $412,396.10. This represents a 47.15 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Jeffrey Bolton purchased 4,000 shares of the business’s stock in a transaction on Thursday, December 12th. The stock was purchased at an average cost of $8.69 per share, for a total transaction of $34,760.00. Following the acquisition, the director now owns 98,144 shares in the company, valued at approximately $852,871.36. The trade was a 4.25 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders own 1.90% of the company’s stock.

Enhabit Company Profile

Enhabit, Inc provides home health and hospice services in the United States. Its home health services include patient education, pain management, wound care and dressing changes, cardiac rehabilitation, infusion therapy, pharmaceutical administration, and skilled observation and assessment services; practices to treat chronic diseases and conditions, including diabetes, hypertension, arthritis, Alzheimer's disease, low vision, spinal stenosis, Parkinson's disease, osteoporosis, complex wound care and chronic pain, along with disease-specific plans for patients with diabetes, congestive heart failure, post-orthopedic surgery, or injury and respiratory diseases; and physical, occupational and speech therapists provide therapy services.